Paul Tudor Jones Care Dx, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Care Dx, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 28,399 shares of CDNA stock, worth $656,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,399
Previous 20,926
35.71%
Holding current value
$656,016
Previous $324,000
173.46%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
50.4MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$105 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$72.7 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$55.7 Million0.45% of portfolio
-
State Street Corp Boston, MA2.04MShares$47 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.23B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...